Physicians Endoscopy (PE), a leader in the development and management of endoscopic ambulatory surgery centers, has announced the launching of a new service line focusing on "hospital re-integration."
GI & Endoscopy
A gastroenterologist and endoscopist at Davis Memorial Hospital in Elkins, W.Va., is now offering capsule endoscopy for the detection and diagnosis of small intestinal disorders, including small bowel tumors and Crohn's Disease, according to a WBOY news report.
Researchers say postpolypectomy colonoscopy intervals can be extended beyond the traditional five-year mark for patients with nonadvanced adenomas, according to a study published in the Journal of Clinical Gastroenterology.
John Saltzman, MD, associate professor of medicine at Harvard Medical School and director of endoscopy at Brigham and Women's Hospital in Boston, and John Abramson, MD, lecturer in healthcare policy at Harvard Medical School, debate whether colonoscopy is the best…
Findings from a nationwide survey suggest many patients suffering from gastroesophageal reflux disease rarely discuss their conditions with a healthcare provider, pointing to the increasing need for dialogue between physicians and patients, according to a news release.
Advertisement
Smoking, diabetes mellitus and obesity may be risk factors for developing sessile serrated adenomas, according to research published in the Journal of Clinical Gastroenterology.
Southgate (Mich.) Surgery Center is providing free colonoscopies throughout March, according to a report from The News-Herald.
Kaiser Permanente San Diego will donate 22 GI procedures, including colonoscopies and sigmoidoscopies, to uninsured patients in need of outpatient procedures through Project Access San Diego on March 26.
Prabhakar Swaroop, MD, has been named director of the new Crohn's and Colitis program at University of Texas Southwestern Medical Center at Dallas, according to a university release.
Thomas Jefferson University has started recruiting patients for a new National Cancer Institute-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer, according to a university news release.